Feminai is a healthcare technology company dedicated to revolutionizing breast cancer diagnostics by making screenings more accurate, accessible, and affordable. Through its research and innovation efforts, Feminai is advancing breast health while working to ensure that women are never left behind as healthcare continues to evolve.

The company is addressing challenges in breast health monitoring by developing technology designed to provide more accessible and convenient breast health assessment. By bringing together healthcare expertise, wearable technology, and artificial intelligence, Feminai is working toward improving the way women engage with breast health monitoring.

AI-Powered Wearable Breast Health Platform

Feminai’s patented technology combines advanced wearable sensors with AI-powered analysis to detect physiological changes associated with breast tissue density and blood flow. The company’s wearable AI platform is designed to provide an accessible and reliable approach to breast health assessment.

By integrating sensor technology with artificial intelligence, Feminai is developing a new approach to breast health monitoring that provides women with a more convenient and comfortable assessment experience. The platform is designed to improve accessibility while contributing to efforts to enhance breast health awareness and monitoring.

Clinical Validation

In first-in-human clinical trials conducted at Sheba Medical Center, Feminai’s technology demonstrated 96% sensitivity and a 98% negative predictive value (NPV). These results demonstrate the potential of Feminai’s platform as a valuable tool in breast health monitoring and diagnostic accessibility.

The company continues to evaluate its technology through research and clinical studies, gathering insights into performance, usability, and participant experience. These efforts support the continued development of Feminai’s wearable AI platform as it progresses through research and validation stages.

Feminai Partners with Midi Health

Feminai launched a pilot program with Midi Health to evaluate the usability, comfort, and practicality of its at-home breast health scanning experience. The pilot offers participants step-by-step guidance, from receiving the Feminai kit to completing scans and sharing feedback.

The study is designed to help Feminai better understand the participant experience, including ease of use, instruction clarity, convenience, and opportunities for future improvements. Participants receive a complete kit containing the Feminai Patch, measuring device, practice patch, alcohol wipes, scan guide, and other necessary materials to complete the session.

How the Feminai At-Home Scanning Process Works

The Feminai pilot provides participants with a guided and straightforward at-home breast health scanning experience. The process begins with receiving the Feminai kit, which includes the materials needed to complete the session.

Participants download and set up the Feminai app, which walks them through the scanning process. They then prepare a private and comfortable space and follow the provided instructions to prepare for their scan.

Before completing the scan, participants use the demo patch and follow the app’s guided placement instructions to become familiar with the process. This step-by-step approach helps participants understand the procedure and complete the experience with greater ease and confidence.

Through participant feedback, Feminai aims to refine its at-home scanning experience and support the development of a more accessible, comfortable, and empowering approach to breast health monitoring.

Privacy & Safety

Feminai prioritizes user privacy and safety throughout its research and pilot programs. The company’s technology is currently being evaluated as part of a research study and is not intended to replace mammograms, MRIs, or professional medical care.

As part of the research study, individual scan results are not provided to participants. Feminai encourages individuals with health concerns to consult their healthcare providers.

Participant data is securely stored using industry-standard encryption and security practices. Access to information is limited to authorized study personnel, and collected information is used solely for research purposes and pilot-related improvements. Feminai does not share personal information without participant permission.

DR. KARNY ILAN | CO-FOUNDER & CEO

Dr. Karny Ilan is a physician, entrepreneur, and the CEO and co-founder of Feminai, a healthcare technology company developing AI-powered solutions to improve breast cancer detection and make breast health assessments more accessible.

Driven by her experience in medicine, Dr. Ilan founded Feminai with a vision to address challenges in breast cancer screening and develop more convenient approaches to early detection and breast health monitoring. She leads the company’s clinical strategy, research initiatives, and efforts to bring accessible healthcare solutions closer to patients.

Through her work at the intersection of medicine, technology, and entrepreneurship, Dr. Ilan is committed to improving women’s health outcomes and expanding access to reliable breast health solutions.